Journal of Lipid Research, Vol 31, 881-888, Copyright © 1990 by Lipid Research, Inc.

ARTICLES

Increased plasma plant sterol levels in heterozygotes with sitosterolemia and xanthomatosis

H Hidaka, T Nakamura, T Aoki, H Kojima, Y Nakajima, K Kosugi, I Hatanaka, M Harada, M Kobayashi and A Tamura
Third Department of Medicine, Shiga University of Medical Science, Japan.

Plasma sterol levels in a family of sitosterolemia and xanthomatosis were determined by a high performance liquid chromatography. Three affected siblings manifested marked xanthomatosis including subcutaneous soft tissues and generalized atherosclerosis. Two other siblings as well as children of the patients did not show such clinical symptoms and signs. Plasma levels of cholesterol, sitosterol, campesterol, and cholestanol in three affected subjects were 190 +/- 18.5, 25.9 +/- 11.6, 16.1 +/- 7.8, 1.84 +/- 0.92 mg/dl (mean +/- SD), respectively. Four daughters of the affected subjects, who should be considered as obligatory heterozygotes, showed moderately increased levels of these sterols (195 +/- 41.7, 1.33 +/- 0.44, 1.56 +/- 0.69, 0.80 +/- 0.28 mg/dl), which were significantly higher than those of normal subjects. Treatment with cholestyramine had little effect on the increased plasma plant sterol levels, but markedly decreased plasma cholestanol concentrations in two affected siblings. This report presents the clinical features of the patients with sitosterolemia and xanthomatosis and also demonstrates that heterozygotes with this disorder have increased plasma levels of plant sterols as well as cholestanol, and suggests that this rare disease might be inherited as an autosomal co-dominant trait in certain cases. The data also indicate that cholestyramine administration was not effective in this family for treatment of sitosterolemia.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S Kidambi and S B Patel Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis J. Clin. Pathol., May 1, 2008; 61(5): 588 - 594. [Abstract] [Full Text] [PDF]

				T Mushtaq, J K Wales, and N P Wright Adrenal insufficiency in phytosterolaemia Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S61 - S65. [Abstract] [Full Text] [PDF]

				J. Wang, T. Joy, D. Mymin, J. Frohlich, and R. A. Hegele Phenotypic heterogeneity of sitosterolemia J. Lipid Res., December 1, 2004; 45(12): 2361 - 2367. [Abstract] [Full Text] [PDF]

				K. R. Wilund, L. Yu, F. Xu, G. L. Vega, S. M. Grundy, J. C. Cohen, and H. H. Hobbs No Association Between Plasma Levels of Plant Sterols and Atherosclerosis in Mice and Men Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2326 - 2332. [Abstract] [Full Text] [PDF]

				M. H. Davidson, K. C. Maki, D. M. Umporowicz, K. A. Ingram, M. R. Dicklin, E. Schaefer, R. W. Lane, J. R. McNamara, J. D. Ribaya-Mercado, G. Perrone, et al. Safety and Tolerability of Esterified Phytosterols Administered in Reduced-Fat Spread and Salad Dressing to Healthy Adult Men and Women J. Am. Coll. Nutr., August 1, 2001; 20(4): 307 - 319. [Abstract] [Full Text] [PDF]

				M. N Vissers, P. L Zock, G. W Meijer, and M. B Katan Effect of plant sterols from rice bran oil and triterpene alcohols from sheanut oil on serum lipoprotein concentrations in humans Am. J. Clinical Nutrition, December 1, 2000; 72(6): 1510 - 1515. [Abstract] [Full Text] [PDF]

				G. M. B. Berger, R. J. Pegoraro, S. B. Patel, P. Naidu, L. Rom, H. Hidaka, A. D. Marais, A. Jadhav, R. P. Naoumova, and G. R. Thompson HMG-CoA reductase is not the site of the primary defect in phytosterolemia J. Lipid Res., May 1, 1998; 39(5): 1046 - 1054. [Abstract] [Full Text]

				S. B. Patel, A. Honda, and G. Salen Sitosterolemia: exclusion of genes involved in reduced cholesterol biosynthesis J. Lipid Res., May 1, 1998; 39(5): 1055 - 1061. [Abstract] [Full Text] [PDF]